EKF Diagnostics Holdings PLC
LSE:EKF
EKF Diagnostics Holdings PLC
Revenue
EKF Diagnostics Holdings PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Revenue
£52.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Smith & Nephew PLC
LSE:SN
|
Revenue
$5.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Revenue
$1.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Revenue
$254.5m
|
CAGR 3-Years
123%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Revenue
£1.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Revenue
£27.2m
|
CAGR 3-Years
1 163%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is EKF Diagnostics Holdings PLC's Revenue?
Revenue
52.6m
GBP
Based on the financial report for Dec 31, 2023, EKF Diagnostics Holdings PLC's Revenue amounts to 52.6m GBP.
What is EKF Diagnostics Holdings PLC's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was -21%. The average annual Revenue growth rates for EKF Diagnostics Holdings PLC have been -7% over the past three years , 4% over the past five years , and 5% over the past ten years .